Kratom, a Southeast Asian plant long used for pain relief and mood support, is at the center of a growing regulatory battle in the United States. Advocates argue consumers need protection from adulterated products, not prohibition, warning that a ban could criminalize users and cut off a potential tool in addressing opioid dependence. The Kratom Consumer Protection Act, already adopted in several states, seeks to mandate testing, clear labeling and age restrictions while banning dangerous additives and artificially boosted alkaloid levels. Federal health agencies, including the National Institute on Drug Abuse, are funding studies that suggest kratom may offer pain relief and support for opioid and alcohol use disorders with lower abuse potential than traditional opioids. The fact sheet underpinning these claims is available at kratomanswers.org
The latest news on the legalization of controversial botanicals.
